{
  "id": "4ef7bd5a01ed2293",
  "title": "Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025",
  "description": "20251209T134500Z",
  "content": "",
  "source": "saltlakecitysun.com",
  "source_url": "http://www.saltlakecitysun.com/news/278745431/aptevo-therapeutics-highlights-compelling-safety-and-strong-remission-rates-for-mipletamig-in-frontline-aml-at-ash-2025",
  "published_at": "20251209T134500Z",
  "fetched_at": "2025-12-10T00:22:54.894572+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "http://www.saltlakecitysun.com/news/278745431/aptevo-therapeutics-highlights-compelling-safety-and-strong-remission-rates-for-mipletamig-in-frontline-aml-at-ash-2025",
    "url_mobile": "",
    "title": "Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025",
    "seendate": "20251209T134500Z",
    "socialimage": "",
    "domain": "saltlakecitysun.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}